Biological efficacy and stability of diluted ticarcillin-clavulanic acid in the topical treatment of Pseudomonas aeruginosa infections

Veterinary Dermatology

Volumn 23, Issue 2, 2012, Pages

  Bateman, Fiona L ^a   Moss, Susan M ^b   Trott, Darren J ^c   Shipstone, Michael A ^a  

^a Dermatology for Animals   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLAVULANIC ACID; TICARCILLIN; TICARCILLIN CLAVULANIC ACID; TICARCILLIN-CLAVULANIC ACID;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; DRUG STORAGE; MICROBIOLOGICAL EXAMINATION; PSEUDOMONAS AERUGINOSA; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CLAVULANIC ACIDS; DRUG STORAGE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; TICARCILLIN;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 84857538826     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2011.01018.x     Document Type: Article

References (13)

1. Matewish M, Lam JS. Pseudomonas. Pathogenesis of Bacterial Infections in Animals. Ames, IA: Blackwell Publishing, 2008: 321-42.
2. Carlotti D, Le Roy S. Otitis externa in the dog: aetiology and clinical findings, literature review and retrospective study of 752 cases. Pratique Médicale et Chirurgicale de l'Animal de Compagnie 1997; 32: 243-57.
3. Nuttall T, Cole LK. Evidence-based veterinary dermatology: a systematic review of interventions for treatment of Pseudomonas otitis in dogs. Veterinary Dermatology 2007; 18: 69-77.
4. Martín Barrasa JL, Lupiola Gómez P, González Lama Z et al. Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa. Journal of Veterinary Medicine, Series B 2000; 47: 191-6.
5. Hirsh D, Jang S. Antimicrobial susceptibility of selected infectious bacterial agents obtained from dogs. Journal of the American Animal Hospital Association 1994; 30: 487-94.
6. Petersen AD, Walker RD, Bowman MM et al. Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997). Journal of the American Animal Hospital Association 2002; 38: 407-13.
7. Robson D, Moss S, Trott D et al. Degradation of in vitro efficacy of refrigerated ticarcillin-clavulanic acid solution against susceptible Pseudomonas aeruginosa and Staphylococcus intermedius isolates over a four-week period. Proceedings of the Australian College of Veterinary Scientists Dermatology Chapter, Science Week. Eight Mile Plains: Australian College of Veterinary Scientists, 2003: 10-11.
8. NCCLS. Methods for Determining Bactericidal Activity of Antimicrobial Agents. Approved Guideline. Document M26-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 1999.
9. Smith J. Laboratory evaluation of antimicrobial agents. In: Denyer S, Hodges N, Gorman S, eds. Hugo and Russell's Pharmaceutical Microbiology, 7th edn. Oxford: Blackwell Science, 2004: 187-201.
10. ® Product Information. Melbourne: GlaxoSmithKline Australia Pty Ltd, 2006.
11. Curtin J, Cormican M. Measuring antimicrobial activity against biofilm bacteria. Reviews in Environmental Science and Biotechnology 2003; 2: 285-91.
12. Fujiwara S, Miyake Y, Usui T et al. Effect of adherence on antimicrobial susceptibility of Pseudomonas aeruginosa, Serratia marcescens and Proteus mirabilis. Hiroshima Journal of Medical Sciences 1998; 47: 1-5.
13. Das J, Bhakoo M, Jones M et al. Changes in the biocide susceptibility of Staphylococcus epidermidis and Escherichia coli cells associated with rapid attachment to plastic surfaces. Journal of Applied Microbiology 1998; 84: 852-8.